Same industry

QGEN against four biotech peers, a year at 100

100200400800Feb ’26MayAugNov ’26AMGN+31.5%GILD+33.4%MRNA×8.3BIIB+43.4%QGEN+5.8%

QGEN +5.8%. Moderna ×8.3, Biogen +43.4%, Gilead Sciences +33.4%, Amgen +31.5%. Weekly closes, Nov 21, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in QGEN’s SEC industry (Biological Products, (No Diagnostic Substances)) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

QGEN: stories, the record and filings →